← All trials
NCT04662294
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 18, 2021
- Primary completion
- Jan 15, 2024
- Completion date
- Jan 15, 2027
- First posted
- Dec 10, 2020
- Last posted
- Nov 4, 2021
- Enrollment
- 108
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Zhejiang UniversityLead sponsor
- Zhejiang UniversityReponsible party - principal investigator
- Yake Biotechnology Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.